These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 38434502)

  • 1. The effects of mouth rinsing and gargling with mouthwash containing povidone-iodine and hydrogen peroxide on the cycle threshold value of Severe Acute Respiratory Syndrome Coronavirus 2: A randomized controlled trial of asymptomatic and mildly symptomatic patients.
    Sulistyani LD; Julia V; Soeprapto A; Swari RP; Rosmanato F; Haryanto B; Cahyarini C; Panjaitan R; Maharani DA
    F1000Res; 2022; 11():1238. PubMed ID: 38988895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can toothbrushing reduce the intraoral viral load of SARS-CoV-2? A pilot study with a dentifrice containing an antimicrobial phthalocyanine derivative.
    Poleti ML; Gregório D; Bistaffa AGI; Vilhena FV; Simão ANC; Mori MTE; Stadtlober NP; Lozovoy MAB; da Silva Santos PS; Tatibana BT; Fernandes TMF
    GMS Hyg Infect Control; 2024; 19():Doc32. PubMed ID: 38993377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Povidone-Iodine as a Pre-Procedural Mouthwash to Reduce the Salivary Viral Load of SARS-CoV-2: A Systematic Review of Randomized Controlled Trials.
    Garcia-Sanchez A; Peña-Cardelles JF; Ordonez-Fernandez E; Montero-Alonso M; Kewalramani N; Salgado-Peralvo AO; Végh D; Gargano A; Parra G; Guerra-Guajardo LI; Kozuma W
    Int J Environ Res Public Health; 2022 Mar; 19(5):. PubMed ID: 35270569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of mouthwashes in reducing SARS-CoV-2 viral loads in human saliva: A systematic review.
    Ziaeefar P; Bostanghadiri N; Yousefzadeh P; Gabbay J; Shahidi Bonjar AH; Ghazizadeh Ahsaie M; Centis R; Sabeti M; Sotgiu G; Migliori GB; Nasiri MJ
    New Microbes New Infect; 2022; 49():101064. PubMed ID: 36530834
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Nazrine S; Kulal R; Shivaprasad BM; Janardhanan N
    J Indian Soc Periodontol; 2023; 27(6):607-611. PubMed ID: 38434502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial.
    Elzein R; Abdel-Sater F; Fakhreddine S; Hanna PA; Feghali R; Hamad H; Ayoub F
    J Evid Based Dent Pract; 2021 Sep; 21(3):101584. PubMed ID: 34479668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of mouthwash on reducing salivary SARS-CoV-2 viral load and clinical symptoms: a systematic review and meta-analysis.
    Zhang M; Meng N; Duo H; Yang Y; Dong Q; Gu J
    BMC Infect Dis; 2023 Oct; 23(1):678. PubMed ID: 37821800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary SARS-CoV-2 load reduction with mouthwash use: A randomized pilot clinical trial.
    Eduardo FP; Corrêa L; Heller D; Daep CA; Benitez C; Malheiros Z; Stewart B; Ryan M; Machado CM; Hamerschlak N; Rebello Pinho JR; Bezinelli LM
    Heliyon; 2021 Jun; 7(6):e07346. PubMed ID: 34189331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore.
    Seneviratne CJ; Balan P; Ko KKK; Udawatte NS; Lai D; Ng DHL; Venkatachalam I; Lim KS; Ling ML; Oon L; Goh BT; Sim XYJ
    Infection; 2021 Apr; 49(2):305-311. PubMed ID: 33315181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlorhexidine mouthwash reduces the salivary viral load of SARS-CoV-2: A randomized clinical trial.
    Costa DD; Brites C; Vaz SN; de Santana DS; Dos Santos JN; Cury PR
    Oral Dis; 2022 Nov; 28 Suppl 2():2500-2508. PubMed ID: 34837305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of the ORF1 Gene Is an Indicator of the Possible Isolation of Severe Acute Respiratory Syndrome Coronavirus 2.
    Shirato K; Kakizaki M; Tomita Y; Kawase M; Takeda M
    Pathogens; 2022 Feb; 11(3):. PubMed ID: 35335626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.
    Feikin DR; Higdon MM; Abu-Raddad LJ; Andrews N; Araos R; Goldberg Y; Groome MJ; Huppert A; O'Brien KL; Smith PG; Wilder-Smith A; Zeger S; Deloria Knoll M; Patel MK
    Lancet; 2022 Mar; 399(10328):924-944. PubMed ID: 35202601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Variants, Vaccines, and Host Immunity.
    Mistry P; Barmania F; Mellet J; Peta K; Strydom A; Viljoen IM; James W; Gordon S; Pepper MS
    Front Immunol; 2021; 12():809244. PubMed ID: 35046961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indian Herb-Derived Phytoconstituent-Based Antiviral, Antimicrobial and Antifungal Formulation: An Oral Rinse Candidate for Oral Hygiene and the Potential Prevention of COVID-19 Outbreaks.
    Sharad S; Kapur S
    Pathogens; 2021 Sep; 10(9):. PubMed ID: 34578161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating salivary carriage of severe acute respiratory syndrome coronavirus 2 in nonsymptomatic people and efficacy of mouthrinse in reducing viral load: A randomized controlled trial.
    Chaudhary P; Melkonyan A; Meethil A; Saraswat S; Hall DL; Cottle J; Wenzel M; Ayouty N; Bense S; Casanova F; Chaney M; Chase H; Hermel R; McClement M; Sesson C; Woolsey B; Kumar P
    J Am Dent Assoc; 2021 Nov; 152(11):903-908. PubMed ID: 34561086
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.